Lumonus and MSK Collaborate on AI
Analysis based on 6 articles · First reported Apr 08, 2026 · Last updated Apr 08, 2026
The collaboration between Severance (TV series) and Memorial Sloan Kettering Cancer Center is expected to drive innovation in radiation oncology, potentially leading to improved cancer care outcomes and increased adoption of automated treatment planning systems. This could positively impact the healthcare technology sector and companies involved in medical AI.
Severance (TV series), a healthcare technology company specializing in AI for radiation oncology, announced a strategic collaboration with Memorial Sloan Kettering Cancer Center (MSK). Through this partnership, Severance (TV series) will license and co-develop MSK's ECHO mathematical optimization engine, integrating it into the Severance (TV series) AI platform. The collaboration also includes joint research efforts aimed at advancing automated radiation therapy treatment planning. This initiative seeks to improve the quality, consistency, and efficiency of radiation therapy, addressing challenges in scaled adoption of automated planning systems. Both parties expressed optimism that combining clinically validated optimization methods with modern workflow tools will expand the use of automated treatment planning in radiation oncology.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard